Track prospects and investment trends across the pharmaceuticals and biotechnology industries

Current Analysis offers actionable insight into how ICT budgets are set to change within pharmaceutical and biotechnology companies, while identifying the technologies that are set to gain the most traction. We also outline likely procurement preferences as well as the approach to operating ICT.

Our analytical reports and premium database products help clients make informed strategic and tactical decisions in targeting the global pharmaceuticals industry.

Pharmaceuticals products and services

  • Models & Forecasts

    We support ICT vendors’ strategic planning by identifying market opportunities and growth across 30+ geographies and 100+ technology categories
  • Account-based Intelligence

    We receive deal and contract information first-hand from the industry. So we're able to keep our clients in touch with the most up-to-the-minute news, providing a valuable first-mover advantage
  • Analysis

    With analytical expertise and extensive primary research we're able to interpret the evolving technology investment landscape. We identify companies' search for new markets and their R&D investments - key factors in their ICT decision making
  • Tools

    We track specialist drug development and individual firms, providing organizational-level insight. We review ICT spending and trends and provide updates on pending contracts offering opportunities for vendors
How to access our solutions for your business

Get in touch to discuss the ways our intelligence solutions can work for your business.

enquiries@currentanalysisgroup.com

UK Tel: +44 (0) 207 936 6400 | US Tel: +1 703 404 9200 / 877 787 8947 (toll free)